focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trial

Mon, 31st Jul 2023 10:46

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Scancell Holdings PLC, up 25% at 11.52 pence, 12-month range 8.65p-29.40p. The cancer immunotherapies developer says it has expanded its Modi-1 trial for the use of checkpoint inhibitors on cancer patients. Scancell says the safety review committee has approved the addition of two new cohorts of 21 patients each. This move follows the successful completion of cohort four of the trial, which showed that patients with renal, head and neck cancer who received at least two doses of Modi-1 combined with CPI tolerated the treatment well, with no safety concerns.

----------

Tertiary Minerals PLC, up 12% at 0.10p, 12-month range 0.083p-0.31p. The mineral exploration and development company says it has received permission from the Forest Department of Zambia to carry out soil sampling in forested areas at its Mukai and Mushima North project licenses. The firm says it is exploring the two license areas for copper, with two targets, C1 and A1, identified at Mushima. Chair Patrick Cheetham says: "Our objective is to now complete soil sampling over the exciting targets we have developed at Mushima North and Mukai as well as at our Konkola West Project. This will enable us to prioritise our Zambian Projects for follow up drilling having already completed similar programmes at our Lubuila and Jacks Projects."

----------

AIM - LOSERS

----------

Aptamer Group PLC, down 45% at 2.64p, 12-month range 2.00p-100.00p. The provider of Optimer binders for use in therapeutics, diagnostics, bioprocessing and research says it has terminated its sale process after announcing it had conditionally completed a fundraise. The company says it conditionally raised GBP3.6 million, and accordingly the board decided to terminate the formal sale process. "The company is not in discussions with any party in relation to a sale and is not in receipt of any approaches," says Aptamer. The company also reveals that Chair Ian Gilham and Interim Chief Executive Officer & Chief Financial Officer Rob Quinn have resigned, effective from August 21. The company announced that it had appointed Steve Hull as chair from the same date, and promoted Andrew Rapson, current head of finance, to CFO.

----------

Jadestone Energy PLC, down 32% at 23.70p, 12-month range 23.00p-103.00p. The oil and gas production company focused on the Asia-Pacific region says production is temporarily shut at Montara floating production storage and offloading facility offshore Australia due to a gas alarm in tank 4S. It says the tank will be emptied, cleaned and inspected over the next few weeks. Production at Montara had only resumed in March after closing down in August of last year for repair activities. Chief Executive Officer Paul Blakeley says: "While disappointing and frustrating to have to shut in Montara again, we will find and repair any additional defect while continuing with the overall planned programme of inspection of the storage tanks on the FPSO. The safety of our personnel, as well as the long-term integrity of the asset, are paramount. We will provide a further update once the inspection of tank 4S is complete."

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Apr 2019 11:19

Scancell gets go-ahead for UK second phase trials of 'SCIB1'

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of 'SCIB1' in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.

Read more
8 Apr 2019 11:34

Scancell Holdings expands IP protection with Japanese patent

(Sharecast News) - Scancell Holdings on Monday won a Japanese patent for its Moditope immunotherapy platform, which stimulates the production of cells that overcome the immune suppression induced by tumours.

Read more
8 Apr 2019 11:27

Scancell Gets Japan Patent Protecting Moditope Immunotherapy Platform

LONDON (Alliance News) - Scancell Holdings PLC on Monday said the Japanese Patent Office has granted a patent providing protection for its Moditope immunotherapy platform.The cancer said T

Read more
20 Mar 2019 13:38

Scancell Holdings Gets Further Patent Protection In US And Europe

LONDON (Alliance News) - Immunotherapy firm Scancell Holdings PLC has received a new patent for its Modi-1 drug candidate in the US, it said on Wednesday.The patent, granted by the US in in

Read more
31 Jan 2019 13:59

Loss Widens As Scancell Continues Moditope Cancer Vaccine Development

LONDON (Alliance News) - Scancell Holdings PLC on Thursday said its loss widened in the first half of its year on mounting administrative expenses as its development of Moditope in Scancell were a

Read more
31 Jan 2019 09:48

Scancell shares slip as losses widen in first half

(Sharecast News) - Cancer immunotherapies developer Scancell Holdings issued its interim results for the six months ended 31 October on Thursday, reporting a loss of £3.24m, widening from £2.02m year-on-year.

Read more
23 Jan 2019 11:20

Scancell loses out on Cancer Research UK grant

(Sharecast News) - Immunotherapies developer Scancell has seen Cancer Research UK pass on its submission into the Grand Challenge research initiative.

Read more
23 Jan 2019 10:41

WINNERS & LOSERS SUMMARY: Metro Bank Slumps 29% On Annual Profit Miss

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 1.9%. The airline was extending gains a

Read more
23 Jan 2019 10:18

Scancell Cancer Vaccine Project Misses Out On Cancer Research UK Grant

LONDON (Alliance News) - Scancell Holdings PLC said Wednesday its Project Blueprint proposal was not selected for the Cancer Research UK Grand Challenge grant.Shares in Scancell were down -

Read more
21 Jan 2019 12:58

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

Read more
21 Jan 2019 12:30

Scancell appoints new heads of research and manufacturing

(Sharecast News) - Immunotherapy developer Scancell Holdings announced the appointment of Dr Samantha Paston as its head of research, and Dr Adrian Parry as its head of manufacturing, on Monday.

Read more
30 Oct 2018 16:33

Scancell Holdings Reports Tumour Rejection Data In Cancer Vaccine

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday that data from its second vaccine from its Moditope platform, Modi-2, showed T-cell response, tumour rejection and increased survival in

Read more
30 Oct 2018 14:36

Scancell pleased with progress on 'Moditope' vaccines

(Sharecast News) - Novel immunotherapies developer Scancell Holdings updated the market on the development of its second vaccine from its proprietary 'Moditope' platform, Modi-2, on Tuesday, reporting that pre-clinical data demonstrated that homocitrullinated peptides induced highly potent T-cell responses, tumour rejection and increased survival in murine models.

Read more
24 Oct 2018 12:28

Oxford Technology VCTs Mostly Report Drop In Net Asset Value

LONDON (Alliance News) - The Oxford Technology-managed venture capital trusts reported interim results on Wednesday, with all but one see a drop in net asset value.Oxford Technology Venture

Read more
24 Oct 2018 10:43

WINNERS & LOSERS SUMMARY: Metro Bank Down Amid Mortgage Competition

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 0.9%. The bank reported a rise in third by

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.